These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23381041)

  • 1. Probability, uncertainty, and prostate cancer.
    Concato J
    Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative prostate cancer screening strategies.
    Labrecque M; Aprikian A
    Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative prostate cancer screening strategies--in response.
    Gulati R; Etzioni R
    Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
    [No Abstract]   [Full Text] [Related]  

  • 5. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
    Klotz L
    Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
    [No Abstract]   [Full Text] [Related]  

  • 6. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

  • 7. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Vickers A
    Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
    [No Abstract]   [Full Text] [Related]  

  • 8. Early detection of prostate cancer: can we have our cake and eat it too?
    Masterson TA; Cary C; Cheng L
    Expert Rev Anticancer Ther; 2016; 16(3):247-9. PubMed ID: 26760708
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer screening.
    Eastham J
    Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
    Subramanian V; Kattan MW
    Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
    [No Abstract]   [Full Text] [Related]  

  • 11. The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States.
    Guo F; He D
    Ann Intern Med; 2015 Oct; 163(8):650-1. PubMed ID: 26502132
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
    Zürcher S
    Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Screening smarter, not harder, for prostate cancer.
    Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for active surveillance for low risk prostate cancer.
    Drost FH; Roobol MJ
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
    Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
    BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
    Andriole GL; Kibel AS
    Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer screening "reloaded".
    Gomella LG
    Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current aspects of prostate cancer screening].
    Jalón Monzón A; Escaf Barmadah S; Viña Alonso LM; Jalón Monzón M
    Semergen; 2017; 43(5):387-393. PubMed ID: 27562331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.